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Abstract
During heart development, epicardial progenitors contribute various cardiac lineages including
smooth muscle cells, cardiac fibroblasts, and endothelial cells. However, their specific contribution
to the human endothelium has not yet been resolved, at least in part due to the inability to expand
and maintain human primary or pluripotent stem cell (hPSC)-derived epicardial cells. Here we first
generated CDH5-2A-eGFP knock-in hPSC lines and differentiated them into self-renewing WT11
epicardial cells, which gave rise to endothelial cells upon VEGF treatment in vitro. In addition, we
found that the percentage of endothelial cells correlated with WT1 expression in a WT1-2A-eGFP
reporter line. The resulting endothelial cells displayed many endocardium-like endothelial cell
properties, including high expression levels of endocardial-specific markers, nutrient transporters
and well-organized tight junctions. These findings suggest that human epicardial progenitors may
have the capacity to form endocardial endothelium during development and have implications for
heart regeneration and cardiac tissue engineering.
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1 | INTRODUCTION
The epicardium is the outermost mesothelium layer of the heart that is
essential for both heart development and cardiac remodeling.1 During
cardiogenesis, a subset of epicardial cells invades the underlying myo-
cardium and contributes to various cardiac lineages, including cardiac
fibroblasts and smooth muscle cells.2 A recent report also suggests an
epicardial origin for a subset of cardiomyocytes,3 although the in vivo
fate mapping studies used to draw this conclusion are susceptible to
artifacts. More recently, human sinoatrial node cardiomyocytes have
been derived from TBX181 progenitor cells that also contribute to epi-
cardial cells,4 but it remains unknown whether WT11/TBX181 epicar-
dial cells can also contribute to cardiomyocyte populations. Similarly,
the epicardial contribution to the developing cardiac endothelium
remains controversial.
In vivo lineage tracing studies have shown that a subpopulation of
coronary endothelial cells arise from the epicardium in the chicken,5
while studies in mice failed to identify a significant epicardial contribu-
tion to endothelial cells via fate mapping using the well-known epicar-
dial cell markers TBX18 and WT1.3,6 Recently, Scleraxis (Scx) and
Semaphorin 3D (Sema3D) were identified as markers of epicardial cells
that contribute to both coronary vascular endothelium and cardiac
endocardium.7 Zhang et al.8 identified natriuretic peptide receptor 3
(NPR3) as a specific endocardial marker and demonstrated their contri-
bution of NPR3-expressing endocardial cells to coronary vessels. The
expression of WT1 in developing human fetal hearts follows a pattern
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starting at the epicardium and extending toward the lumen of the heart,
and WT1 expression in endocardial cells nearly disappeared at week 20,
suggesting WT11 epicardial cells as a potential cell origin of endocardial
endothelial cells.9 However, understanding of the developmental pro-
gression of human epicardial cells to endothelium and endocardium is
still extremely limited, mainly due to ethical and logistical challenges of
tracing cells in the developing human heart and the lack of an in vitro
human model to study the epicardial-to-endothelial transition.
Over the past 3 years, multiple labs have developed robust proto-
cols to generate epicardial-like cells from human pluripotent stem cells
(hPSCs) by manipulating Wnt, bone morphogenetic protein and retinoic
acid signaling pathways that are important for in vivo epicardium
development.10–13 While hPSC-derived epicardial cells from different
protocols have the potential to differentiate into smooth muscle cells
and cardiac fibroblasts both in vitro and in vivo, none of them have yet
been shown to form endothelial cells so far. To develop an hPSC model
to study epicardial cell differentiation to endothelial cells, we first gen-
erated CDH5-2A-eGFP knock-in hPSC lines and differentiated them
into self-renewing WT11 epicardial cells which gave rise to endothelial
cells upon VEGF treatment in vitro. We also showed that the purity of
epicardial-derived endothelial cells is proportional to WT1 expression in
a WT1-2A-eGFP reporter line. In addition, the resulting epicardial-
derived endothelial cells displayed many endocardium-like endothelial
cell (EEC) properties, including high expression levels of specific endo-
cardial markers, nutrient transporters and well-organized tight junctions.
These findings demonstrate that hPSC-derived epicardial cells have the
capacity to differentiate to endocardial-like cells for potential applica-
tions in heart tissue engineering and suggest that human epicardial cells
may contribute to endocardial cells during cardiac development.
2 | RESULTS
2.1 | Generation of CDH5-2A-eGFP knock-in reporter
hPSCs via CRISPR/Cas9 genome editing
In order to better monitor the transition of hPSC-derived epicardial
cells to endothelial cells, we engineered the H9 human embryonic stem
cell (hESC) line via CRISPR/Cas9-catalyzed homology-directed repair
(HDR) and generated a homozygous CDH5-2A-eGFP knock-in reporter
cell line (Figure 1a). Two 2-kilobase homologous arm sequences located
before and after the CDH5 stop codon were inserted into the Oct4-
2A-eGFP donor plasmid14 and replaced the Oct4 homologous arms.
We then introduced the 2A-eGFP sequence into the targeting sites by
transfecting hPSCs with the CDH5-2A-eGFP donor plasmid and the
Cas9/sgRNA plasmids. After puromycin selection, PCR genotyping
showed that 90% (64/72) of the clones were targeted in at least one
and 40% (32/72) in both alleles (Figure 1b). The homozygous clones
were then subjected to TAT-Cre recombinase treatment and the PGK-
Puro cassette was excised from CDH5-2A-eGFP (Figure 1c). CDH5-
2A-eGFP-targeted hPSCs after Cre-mediated excision of the PGK-Puro
cassette were subjected to endothelial cell differentiation via a previ-
ous published protocol.15 Dual immunostaining with anti-CD31 and
anti-GFP antibodies showed expression of eGFP in CD311 cells
(Figure 1d), demonstrating success in generating a CDH5 reporter cell
line for potential cell tracking or purification. We also successfully
knocked the 2A-eGFP cassette into the H13 hESC line (Supporting
Information Figure S1).
2.2 | VEGF signaling permits endothelial transition
from hPSC-derived epicardial cells
We previously demonstrated that temporal modulation of canonical
Wnt signaling was sufficient to generate self-renewing
WT11TBX181 epicardial cells from hPSCs.10 Treatment of undiffer-
entiated hPSCs with the GSK3b inhibitor CHIR99021 resulted in mes-
oderm formation and subsequent inhibition of Wnt signaling via a
Porcupine inhibitor directed the cells to ISL11NKX2.51 cardiac pro-
genitors. Treating the cardiac progenitors with CHIR99021 from days
7 to 9 of differentiation generated a virtually pure population of epicar-
dial cells which did not express the endothelial cell markers CD31 and
VE-cad (Figure 2a,b). Upon 50 ng/ml VEGF treatment in EGM-2
medium for 5 days, a small subset of these WT11TBX181 expressing
epicardial cells became VE-Cad1 vWF1 endothelial cells (Figure 2c,d).
Next, we tested different concentrations of VEGF in generating endo-
thelial cells from epicardial cells, and found that 50 and 100 ng/ml
VEGF significantly improved the epicardial-to-endothelial transition
compared to the no-VEGF control (Supporting Information Figure S2a,
b). To further confirm these endothelial cells arose from WT11 epicar-
dial cells, we generated ES03 WT1-2A-eGFP knock-in hPSCs and dif-
ferentiated them into WT11 epicardial cells,10 which were expanded
for several passages in LaSR basal medium containing 0.5 mM A83-01,
which permits expansion and inhibits dedifferentiation of hPSC-
derived epicardial cells,10 and then sorted the cells into populations
expressing high (52.863.3%), medium (36.863.0%), and undetectable
levels (10.460.7%) of WT1 by fluorescence activated cell sorting
(FACS) (Figure 2e). These populations were then subjected to 100 ng/
ml VEGF in EGM-2 medium. Interestingly, we observed the most VE-
cad1 cells from epicardial cells exhibiting high expression of WT1
while the WT1-cells did not generate cells expressing detectable VE-
cad (Figure 2e, Supporting Information Figure S2c). This is consistent
with previous avian studies demonstrating epicardial cells give rise to
endothelial cells.16–18
2.3 | Endothelial cells from WT11 cells display
endocardial properties
Previously, TGFb inhibition via A83-01 treatment was shown to pro-
mote proliferation of hPSC-derived endothelial cells.19 To increase the
yield of endothelial cells from hPSC-derived epicardial cells, we treated
the cells with 2.5 mM A83-01 for 5 days after VEGF treatment. A83-01
treatment doubled the purity of VE-cad1 cells to 2.6%, as expected
(Figure 3a,b). The resulting epicardial-derived endothelial cells
expressed hallmark endothelial cell markers CD31, ICAM-1, and vWF,
as well as the tight junction protein occludin (Figure 3c, Supporting
Information Figure S3). Intriguingly, these epicardial-derived endothelial
cells strongly expressed the EEC-marker NFATc120–22 and the nutrient
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transporter protein Glut-1, compared to endothelial cells differentiated
from hPSCs through a nonepicardial pathway in LaSR basal medium
(LEC)15,23 and human umbilical vein endothelial cells (HUVEC) (Figure
4a,b). In summary, A83-01 treatment increased the purity of
endocardial-like endothelial cells from WT11 cells, and they displayed
specific EEC markers. This is consistent with an in vivo report that epi-
cardial cells can give rise to NFATc11 endocardial cells during mouse
heart development.7
2.4 | Characterization of hPSC-derived EECs
In order to further confirm the endocardial identity of these putative
hPSC-derived EECs, we differentiated VE-cad-2A-eGFP knock-in cell
lines into epicardial cells and then subjected these cells to sequential
VEGF and A83-01 treatment as shown in Figure 3a. On day 10, both
H9 and H13 cell lines yielded  2.5% VE-cad1 cells (Figure 5a,
Supporting Information Figure S4), which were then purified via FACS
for VE-cad expression and subjected to RNA-seq analysis. We first
compared the expression of known endothelial lineage-specific signa-
ture genes in hPSC-derived EECs, human cardiac microvascular endo-
thelial cells (hCMECs), HUVECs (GSE54384), human aortic ECs
(hAECs), mouse cardiac vascular endothelial cells (msVECs),8 and
mouse EECs (msEECs)8 (Figure 5b). EEC marker genes such as
GATA4,24 NFATc1,20–22 NPR38 and GPR126,8 and tight junction genes
and nutrient transporters including occludin (OCLN),25 ZO1 (TJP1),25
and GLUT-1 (SLC2A1),25 were highly enriched in hPSC-derived EECs
FIGURE 1 Generation of CDH5-2A-eGFP knock-in H9 hESC lines using Cas9 nuclease. (a) Schematic diagram of the targeting strategy at
the stop codon of the CDH5 locus. Vertical arrows indicate sgRNA1 and sgRNA2 targeting sites. Red and blue horizontal arrows indicate
PCR genotyping primers for assaying CDH5 locus targeting and homozygosity, respectively. (b) Representative PCR genotyping of hESC
clones after puromycin selection. The expected PCR product for correctly targeted CDH5 locus is 3 kb (red arrows) with an efficiency of
64/72 clones. Correctly targeted clones underwent a further homozygosity assay. Clones with the PCR products of 200 bp are heterozy-
gous (blue arrow), and those clones without PCR products are homozygous. (c) PCR genotyping of hESC clones after TAT-Cre mediated
excision of the PGK-Puro cassette. Clones with PCR products of 1 kb are PGK-Puro free, and those with 3 kb contain PGK-Puro. (d)
Representative CD31 and eGFP dual immunostaining images of CDH5-2A-eGFP hPSC-derived endothelial cells after excision of the PGK-
Puro cassette. Scale bars, 50 mm
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and msEECs, while cardiac vascular endothelial cell marker genes
including APLN,8 FABP4,8 and GPIHBP18 were highly enriched in
hCMECs and msVECs. We also performed gene set enrichment analy-
sis (GSEA) to identify significantly enriched pathways (p< .05) in each
cell type relative to undifferentiated hPSCs. We compared the differen-
ces and similarities in the enriched pathways among hPSC-derived
EECs, hPSC-derived epicardial cells, and mouse EECs (Figure 5c). We
observed that while 9 pathways were commonly enriched in all three
cell types, hPSC-derived EECs shared 27 enriched pathways with
mouse EECs, but only 6 with hPSC-derived epicardial cells (Tables 1–
2). As expected, both hPSC-derived EECs and msEECs, but not hPSC-
derived epicardial cells, were highly enriched in angiogenesis and
FIGURE 2 VEGF exposure directs a subset of hPSC-derived epicardial cells to endothelial cells. (a) Schematic of the protocol for differen-
tiation of hPSC-derived cardiac progenitors to epicardial cells via CHIR treatment. At day 12, cells were subjected to immunostaining analy-
sis of VE-cadherin, CD31, WT1, and TBX18, and representative images are shown in (b). Scale bars, 100 mm. (c) Schematic of the protocol
for differentiation of hPSC-derived epicardial cells to endothelial cells via 5-day VEGF treatment in EGM-2 medium. After 10 days, cells
were analyzed for vWF and VE-cadherin expression by immunostaining (d). Scale bars, 50 mm. (e) WT1-2A-eGFP1 epicardial cells were
FACS sorted according to the GFP signal (red: high (52.8 6 3.3%), yellow: medium (36.8 6 3.0%), and blue: negative (10.4 6 0.7%)) and dif-
ferentiated into endothelial cells as shown in (C). On day 10, differentiation cultures were subjected to VE-cadherin immunostaining and
representative images are shown. Scale bars, 100 lm
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vasculature development-related pathways. Interestingly, the hPSC-
derived EECs and msEECs were also enriched in regulation of body
fluid levels and hemostasis, perhaps resulting from their functions as a
blood-heart barrier (BHB). In addition, hierarchical clustering analysis of
RNA-seq expression data of hPSCs,10 hPSC-mesoderm10 (Mes), hPSC-
cardiomyocytes10 (CMs), hPSC-epicardial cells10 (Epi), hPSC-EECs,
hCMECs, and HUVECs showed that hPSC-derived EECs were most
closely related to the two endothelial cell types (hCMECs and
HUVECs), and were distinct from all other cell populations as a group
(Figure 5d). Next, we explored the developmental relationships
between different cardiac cell types by performing principal component
analysis (PCA) on the gene expression data. Undifferentiated hPSCs
clustered relatively close to Mes cells, from which Epi and CMs diver-
gently formed, in the 3D scores plot for the first 3 principal compo-
nents (Figure 5e). Importantly, hPSC-derived EECs, closer to hCMECs,
were distinct from epicardial cells. Taken together, our hPSC-derived
EECs, like mouse EECs, displayed molecular signatures of endocardial
endothelial cells.
3 | DISCUSSION
The endocardium is the innermost endothelial layer of the heart, serv-
ing as a BHB, an endothelial layer that regulates the ionic composition
of the cardiac microenvironment via passive tight junctions and active
transporter systems. The endocardium also modulates myocardium
performance by releasing trophic factors in response to humoral and
mechanical stimuli.26–28 In addition to its signaling roles during heart
development and regeneration, the endocardium has also been shown
to contribute multi-lineage descendants to cardiac valves, septa, hema-
topoiesis, and coronary blood vessels.29–31 Endocardial endothelium
lesions and other dysfunctions are associated with various cardiovascu-
lar diseases, including parietal endocarditis, intraventricular thrombi in
myocardial infarction, and hypereosinophilic endomyocardial fibro-
sis.32,33 Despite the importance of the endocardium for heart develop-
ment and function, the embryonic origin of endocardium and the
underlying molecular mechanisms that regulate endocardium develop-
ment remains poorly understood, especially in humans.
hPSCs provide a unique model to understand the developmental
mechanisms regulating the specification of human cell lineages. This
model enables systematic studies to identify cues that control develop-
mental fate choices and can also produce cells for patient-specific cell
therapies. Here, we show that activation of Wnt signaling directs hPSC-
derived cardiac progenitors toward epicardial cells, some of which give
rise to endothelial cells upon VEGF treatment. The resulting epicardial
cell-derived endothelial cells displayed many characteristics of endocar-
dial endothelial cells, including expression of key EEC proteins CD31,
VE-cadherin and NFATc1, and elevated Glut-1 expression. These hPSC-
derived EECs also express and exhibit junctional localization of barrier
FIGURE 3 WT11 cell-derived endothelial cells display endocardial-like properties. (a) Schematic of the process for differentiation of hPSC-
derived epicardial cells to EECs. (b) On day 10, cultures differentiated in the absence and presence of A83-01 were subjected to flow
cytometry analysis of VE-cadherin and representative dot plots are shown. Numbers represent the percentage of cells in the indicated gated
regions. (c) Representative immunostaining images of endothelial markers VE-cadherin, CD31, and ICAM-1, as well as tight junction protein
occludin in cells differentiated as shown in (a). Scale bars, 50 mm
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proteins such as occludin and ZO1, and exhibit global gene expression
profiles as mouse primary EECs. Previous studies have generated epicar-
dial cells from hPSCs and differentiated them into smooth muscle cells
and cardiac fibroblasts.11–13 These hPSC-derived epicardial cells had not
been differentiated to endothelial cells, however. Using a WT1-2A-eGFP
reporter cell line, we showed that WT11 epicardial cells can give rise to
endocardial-like endothelial cells. To our knowledge, this is the first
employment of an in vitro reporter system to confirm the epicardial-to-
endothelial transition. Our finding is consistent with the in vivo observa-
tion that epicardial cells, marked by SCX/Sema3D, can give rise to
NFATc11 endocardial cells during mouse heart development.7
The epicardial contribution to the endocardium in vivo in animal
models is small likely due to the fact that endocardial tubes form
before the epicardium during heart development,7 which might also
explain the low efficiency (2%) of epicardial-to-endocardial transition
even with high VEGF in our hPSC model. Therefore, there may be
other cardiac progenitors that contribute to the majority of the
endocardium. Compared to the epicardium, mesodermal progenitor
cells marked by Flk11 are better established as origins for endocar-
dium in both chicken and mice embryos before primary heart field
formation.34–37 In addition, Isl11 second heart field progenitors were
shown to give rise to the endocardium by re-expressing Flk1.38,39
However, generation of human endocardium from either Flk11 or
Isl11 progenitors have not yet been described. Based on cardiac devel-
opmental studies in animal models, we expect that multiple progenitor
populations may contribute to endocardial formation in humans.
FIGURE 4 Immunostaining comparison of endocardial cell marker NFATC1 (a) and nutrient transporter protein Glut-1 (b) in different types of
endothelial cells. EEC: hPSC-derived endocardial endothelial cells; LEC: Endothelial cells differentiated from hPSCs in LaSR basal medium;
HUVEC: Human umbilical vein endothelial cells. DAPI and vWF co-staining indicate nuclei and endothelial cells, respectively. Scale bars, 50 mm
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A better understanding of endocardium development will assist
development of novel approaches to efficiently generate functional
EECs that can be used in basic and translational applications. First,
EECs may provide functional improvements in engineered myocardium
and heart valve tissues. Including vascular endothelial cells in human
heart tissues was shown to significantly improve engraftment rates and
cardiac functions in infarcted hearts.40,41 As a BHB, EECs might pro-
vide a more unique niche to modulate cardiac contraction and support
cardiac function within engineered tissues and infarcted hearts. Sec-
ond, hPSC-derived endocardium can be employed as an in vitro model
to study molecular mechanisms that regulate endocardium develop-
ment and dysfunction, as well as mechanotransduction and signaling in
response to blood flow and stress. For example, Nemer and Nemer
showed that inhibition of GATA5 expression in an in vitro model of
mouse endocardial differentiation blocks endocardial cell formation.22
Lastly, EECs can also be used to develop in vitro endocardium-
FIGURE 5 Molecular profiling of hPSC-derived EECs. (a) H13 VE-cad-2A-eGFP-derived epicardial cells were differentiated into EECs
according to Figure 3a, and cells were subjected to flow cytometry analysis for GFP expression at the indicated days. Data represent
mean6SEM of five independent replicates. (b) Expression of the endothelial subtype marker genes quantified by the normalized RPKM
from RNA-seq. Markers of different subtypes are indicated with colored bars. Black: standard endothelial markers; red: EEC-enriched
markers; yellow: cardiac vascular endothelial cell (VEC)-enriched markers; blue: barrier-related genes. hCMEC: human cardiac microvascular
endothelial cells; HUVEC: human umbilical vein endothelial cells; hAEC: human aortic endothelial cells; msVEC: mouse cardiac vascular
endothelial cells; msEEC: mouse endocardial endothelial cells. (c) Venn diagram showing the number of pathways which were enriched in
different cell types relative to undifferentiated hPSCs. (d) Hierarchical clustering analysis of RNA-seq expression data of hPSCs, hPSC-
derived mesoderm (Mes), cardiomyocytes (CMs), epicardial cells (Epi), and EEC, as well as primary hCMEC and HUVEC. (e) 3D scores plot
of first 3 principal components (PCs) from PC analysis (PCA) of RNA-seq data. The ellipses show the 95% confidence limits and each data
point corresponds to a unique biological sample. Black arrows show the differentiation progression from mesoderm to CMs and epicardial
cells, from which EEC arise
TABLE 1 Gene annotations enriched in hPSC-derived EECs and
epicardial cells and murine EEC compared to undifferentiated
hPSCs
GO Description Size




Positive regulation of cell differentiation 21
Extracellular matrix part 49
Skeletal development 79
Regulation of cell adhesion 28
Muscle development 88
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myocardium co-culture systems to study the paracrine or direct-
contact interactions as these cellular communications are crucial for
normal heart development and function. Such a co-culture system
might help to identify key regulators of cardiomyocyte maturation
which would improve efforts to regenerate the damaged heart. How-
ever, to make these applications practical, it will necessary to increase
the purity and yield of VE-cad1 cells from hPSC-derived epicardial
cells and to develop strategies to expand hPSC-derived EECs. Enhanc-
ing WT1 expression levels in epicardial cells, use of a 3D culture sys-
tem, addition of growth factors in addition to VEGF, and co-culture
with physiologically relevant cardiac cells may improve EEC differentia-
tion or self-renewal.
In summary, our results demonstrate that a subset of human endo-
cardial endothelial cells arise from hPSC-derived WT11 epicardial cells
in vitro (Supporting Information Figure S5), providing a more complete
understanding of the epicardial progenitor populations that form the
endothelium, and a method to produce human endocardial endothelial
cells for both research and translational applications.
4 | MATERIALS AND METHODS
4.1 | Construction of donor plasmid and sgRNA
Dual Cas9 and sgRNA backbone was digested with BbsI restriction
enzyme for rapid sgRNA cloning as previously described.10 Two
sgRNAs targeting near the CDH5 stop codon (1: TCAGCCAG-
CATCTTAAACCTGGG and 2: TTTTTGGAGGCTGTGGTGCCTGG)
with a G added at the beginning were used. To generate the CDH5-






Regulation of body fluid levels 42
Bone remodeling 20
Mesoderm development 20
Extracellular matrix structural constituent 22
Regulation of angiogenesis 23
Vasculature development 47
Angiogenesis 40
Rho protein signal transduction 36
Anatomical structure formation 48
Negative regulation of cell adhesion 16
Insulin receptor signaling pathway 19
Integrin complex 17
Heart development 33
Transmembrane receptor protein serine threonine kinase signaling pathway 42
Ras protein signal transduction 64
Cell substrate adhesion 38
Small GTPase mediated signal transduction 84
Transforming growth factor beta receptor signaling pathway 32
Membrane organization and biogenesis 118
Jak stat cascade 27
Cell Matrix Adhesion 37
Small GTPase regulator activity 67
Enzyme linked receptor protein signaling pathway 122
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2A-eGFP donor plasmid, DNA fragments of about 2kb in length
were PCR amplified from genomic DNA before and after the stop
codon of CDH5 and were cloned into the OCT4-2A-eGFP
donor plasmid14 (Addgene #31938), replacing the OCT4 homologous
arms.
4.2 | Maintenance of hPSCs and TAT-Cre treatment
of CDH5 knock-in hPSCs
Transgene and vector-free hPSCs were maintained on Matrigel (Corn-
ing) or SyntheMax (BD Biosciences)-coated plates in mTeSR1 or E8
medium (STEMCELL Technologies) according to previously published
methods.42,43 To remove the PGK-Puro cassette from the CDH5-2A-
eGFP cells, targeted homozygous clones were treated with 2 lM TAT
Cre Recombinase (Excellgen, EG-1001) for 6 hr in E8 medium. After 2
days, cells were singularized with Accutase (Innovative Cell Technolo-
gies) and seeded into a Matrigel-coated 96-well plate at a density of
100–150 cells per well. After 2 weeks, cells were subjected to PCR
genotyping.
4.3 | Electroporation
hPSCs pretreated with 10 lM ROCK inhibitor (Y27632) for 3 to 4 hr
prior to electroporation. Cells were digested by Accutase at 37 8C for 8
min and 2.5–3 million singularized cells were electroporated with 3 lg
gRNA1, 3 lg gRNA2, and 6 lg CDH5-2A-eGFP donor plasmids in 200
ll cold PBS -/- using the Gene Pulser Xcell System (Bio-Rad) at 320 V,
200 lF, and 1,000 X (Time constant should be around 15 ms) in a
0.4 cm cuvette. Two electroporations were performed and in total 5–6
million cells were subsequently plated onto a Matrigel-coated 10-cm
dish in 10 mL mTeSR1 with 10 lM Y27632. Twenty-four hours later,
and every day afterward, the medium was changed with fresh mTeSR1.
Three days after electroporation, 1 lg/ml puromycin was added to the
mTeSR1 for selection for about 2 weeks. Single cell clones were then
picked into wells of a Matrigel-coated 96-well plate and subjected to
PCR genotyping after 4–7 days.
4.4 | Epicardial cell generation via modulation of
canonical Wnt signaling
Day 6 cardiac progenitor cells and epicardial cells were generated as
previously described.10,44,45 Briefly, cardiac progenitor cells were singu-
larized with Accutase at 37 8C for 5 min and then seeded onto a
gelatin-coated cell culture dish at 20,000–80,000 cells/cm2 in LaSR
basal medium (advanced DMEM/F12 with 100 mg/ml ascorbic acid) or
RPMI/Vc/Ins medium (100 mg/ml ascorbic acid and 1 mg/ml human
recombinant or bovine insulin) with 5 lM ROCK inhibitor Y-27632 for
24 hr. At day 7 after initiation of differentiation, cells were treated with
3 mM CHIR99021 for 2 days in LaSR basal medium or RPMI/Vc/Ins
medium. After 2 days, CHIR99021-containing medium was aspirated
and cells were cultured in LaSR basal medium or RPMI/Vc/Ins medium
without CHIR99021 for 3–5 additional days.
4.5 | Endothelial cell differentiation from hPSC-
derived epicardial cells
After maintenance in LaSR basal medium containing 0.5 mM A83-01
for several passages, confluent hPSC-derived epicardial cells were split
1:3 to 1:6 at a density of 0.04 to 0.08 million cells/cm2 using Versene
(Life Technologies) or Accutase onto gelatin-coated plates. When
reaching more than 60% confluence, epicardial cells were cultured in
EGM-2 medium containing 100 ng/ml VEGF for 5 days followed by 5
days in EGM-2 medium containing 2.5 mM A83-01.
4.6 | Immunostaining analysis
Cells were fixed with 4% paraformaldehyde for 15 min at room tem-
perature and then stained with primary and secondary antibodies (Sup-
porting Information Table S1) in PBS plus 0.4% Triton X-100 and 5%
non-fat dry milk (Bio-Rad). Nuclei were stained with Gold Anti-fade
Reagent with DAPI (Invitrogen). An epifluorescence microscope (Leica
DM IRB) with a QImaging® Retiga 4000R camera was used for imag-
ing. The quantification of VE-cad1 cells in Supporting Information Fig-
ure S2b,c were performed using Image J.
4.7 | Genomic DNA extraction and genomic PCR
QuickExtractTM DNA Extraction Solution (Epicentre Cat. # QE09050)
was used to rapidly extract genomic DNA from hPSCs according to the
manufacturer’s instructions. Genomic PCR was carried out using GoTaq
Green Master Mix (Promega Cat. # M7123). PCR primer sequences are
provided in the Supporting Information Table S2.
4.8 | RNA sequencing and data analysis
Human primary cardiac microvascular endothelial cells were purchased
from PromoCell. Total RNA of corresponding samples was prepared
with the Direct-zolTM RNA MiniPrep Plus kit (Zymo Research) accord-
ing to the manufacturer’s instructions. Samples were analyzed in an
Illumina HiSeq 2500 by Biotechnology Center at University of
Wisconsin-Madison. The resulting sequence reads were mapped to the
human genome (hg19) using HISAT,46 and the RefSeq transcript levels
(RPKMs) were quantified using the python script rpkmforgenes.py.47
Hierarchical clustering of whole transcripts was then plotted using
GENE-E. PCA was performed using PLS Toolbox 8.1 (Eigenvector
Technologies). The whole transcripts were preprocessed using an auto-
scaling method (subtracting the mean from the variables and dividing
by the standard deviation) to study the variance. Pathway enrichment
analysis was performed using GSEA software.48 The gene expression
data for each cell type were compared to expression data from undif-
ferentiated hPSCs and the significantly enriched pathways (p< .05)
were considered for further analysis. MATLAB 2013a (MathWorks
Inc.) and Microsoft Excel (2013) were used to identify the unique and
common pathways in different cell types. The final processed data and
raw fastq files were submitted to Gene Expression Omnibus with the
accession number GSE93705.
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5 | CONCLUSIONS
This study demonstrates that hPSC-derived WT11 epicardial progeni-
tor cells can give rise to endothelial cells that display properties of
endocardial endothelial cells. This suggests that a subset of human
endocardial cells may have origins in the epicardium and identifies
hPSC-derived epicardial cells a potential source for endocardial tissue
engineering and regenerative medicine.
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